Diagnostic and prognostic relevance of inflammatory markers in surgically treated thymic epithelial tumors: An international multicenter study

Lung, Respiratory and Thoracic Cancer

Tumour dimension is a prognostic factor in thymic epithelial tumours: An update analysis from the ESTS thymic database: Tumour dimension in thymic tumours

Lung Cancer

Chiappetta M, Lococo F, Sassorossi C, Moser B, Schil PV, Podobed A, Liberman M, Opitz I, Zisis C, Menghesha H, Furak J, Mendogni P, Ruffini E, Guerrera F, Venuta F, Voltolini L, Londero F, Casiraghi M, Bravio I, Voulaz E, Barmin V, Trancho FH, Billè A, Cafarotti S, Campanella A, Santoro G, Novoa NM, Margaritora S, ESTS Working Group, ESTS Thymic Database Participants

doi: 10.1016/j.lungcan.2025.108535

Gastrointestinal Cancer

Circulating tumor DNA as prognostic marker in patients with metastatic colorectal cancer undergoing systemic therapy: A systematic review and meta-analysis

Cancer Treat Rev

Holz A, Paul B, Zapf A, Pantel K, Joosse SA

doi: 10.1016/j.ctrv.2025.102999

Lung, Respiratory and Thoracic Cancer

Deep Learning Discriminates Thymic Epithelial Tumors Histological Subtypes Using Digital Pathology

Ann Oncol

Sacco M, Pietroluongo E, Di Lello A, Marino M, McGeough A, Esposito A, Sharma R, Husain AN, Arif Q, Elsebaie MAT, Pearson AT, Dolezal JM, Garassino MC

doi: 10.1016/j.annonc.2025.12.003

Central Nervous System Tumors

Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von-Hippel-Lindau Disease: A multicenter study

Neuro Oncol

Wach J, Basaran AE, Vychopen M, Tihan T, Wostrack M, Butenschoen VM, Meyer B, Siller S, Schmidt NO, Onken J, Vajkoczy P, Santos AN, Rauschenbach L, Dammann P, Sure U, Klingler JH, Doria-Medina R, Beck J, Blaß BI, Gizaw CJ, Hohenhaus R, Krieg S, Alhalabi OT, Klein L, Thomé C, Kögl N, Kunert P, Czernicki T, Pantel T, Middelkamp M, Eicker SO, Kattaa AH, Park DJ, Chang SD, Kilinc F, Czabanka M, Güresir E

doi: 10.1093/neuonc/noaf041

Lung, Respiratory and Thoracic Cancer

The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study

Lung Cancer

Rolfo C, Gerber DE, Kotecha R, Ward JP, Akerley W, Weiss L, Naveh A, Shapira N, Leal T, Langer CJ, LUNAR study investigators

doi: 10.1016/j.lungcan.2025.108802

Lymphoma

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial

Am J Hematol

Durmo R, Chauvie S, Minoia C, Bergesio F, Fallanca F, Peano S, Marcheselli L, Anastasia A, Boccomini C, Corradini P, Olivieri J, Arcaini L, Cavallo F, Ibatici A, Nassi L, Tarantino V, Pinto A, Stelitano C, Pulsoni A, Ricci F, Mancuso S, Cencini E, Di Renzo N, Mannarella C, Palmas A, Zinzani P, Bocci C, Rossi F, Carella AM, Federico M, Versari A, Guerra L, Luminari S

doi: 10.1002/ajh.27711

Gastrointestinal Cancer

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

J Clin Oncol

Babiker HM, Picozzi V, Chandana SR, Melichar B, Kasi A, Gang J, Gallego J, Bullock A, Chunyi H, Wyrwicz L, Hitre E, Osipov A, de la Fouchardiere C, Ales I, Dragovich T, Lee W, Feeney K, Philip P, Ueno M, Van Cutsem E, Seufferlein T, Macarulla T, PANOVA-3 Study Investigators

doi: 10.1200/JCO-25-00746

Lung, Respiratory and Thoracic Cancer

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

Ann Oncol

Zheng MM, Xia Y, Pan K, Sun F, Tan AC, Dong XR, Tu HY, Tang LB, Li YS, Yin K, Borgeaud M, Singhal S, Zhu E, Zhang J, Nilsson M, Wu J, Gibbons DL, Wakelee H, Neal JW, Lee J, Vaporciyan AA, Ringsurongkawong W, Tran HT, Zhang RZ, Zhang T, Zhou Q, Zhong WZ, Li W, Zhang YC, Riess JW, Addeo A, Heymach JV, Myall N, Tan D, Wu YL, Le X

doi: 10.1016/j.annonc.2025.09.140

Gynecologic Cancer

Risk of epithelial ovarian tumors among women diagnosed with hypo- and hyperthyroidism: Findings from a large nationwide cohort study

Cancer Epidemiol Biomarkers Prev

Jensen A, Gottschau M, Christensen J, Lindquist S, Aalborg GL, Rosthøj S, Grand MK, Pedersen J, Nøhr B, Kjaer SK

doi: 10.1158/1055-9965.EPI-25-1668

Related content

Tumour dimension is a prognostic factor in thymic epithelial tumours: An update analysis from the ESTS thymic database: Tumour dimension in thymic tumours

Circulating tumor DNA as prognostic marker in patients with metastatic colorectal cancer undergoing systemic therapy: A systematic review and meta-analysis

Deep Learning Discriminates Thymic Epithelial Tumors Histological Subtypes Using Digital Pathology

Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von-Hippel-Lindau Disease: A multicenter study

The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

Risk of epithelial ovarian tumors among women diagnosed with hypo- and hyperthyroidism: Findings from a large nationwide cohort study